Diagnosis Of Bronchogenic Carcinoma Research Articles

Bronchogenic carcinoma in patients undergoing solid organ transplant. The role of surgery

BackgroundThe incidence of neoplastic diseases is higher in patients undergoing solid organ transplant. However, the incidence of bronchogenic carcinoma (BC) is controversial. The objective of our study was to determine the incidence of BC in a large cohort of transplant patients and the role of surgery. Material and methodsUntil December 2006, 3596 patients underwent solid organ transplant at our institution; 24 (0.7%) patients subsequently developed BC, of which 6 (24%) were classified as clinical stage I and submitted to surgical treatment. Survival was estimated by the Kaplan-Meier method. ResultsThree patients received a liver transplant, 2 a kidney transplant and 1 a heart transplant. All were male and all had a smoking history. Mean age was 58.6 years. Two patients had cough, one accompanied by bloody expectoration, and BC was an incidental finding in the remaining cases. The interval between transplant and diagnosis of BC was 38.1 months. Epidermoid carcinoma was the most frequent histological type. Mean tumour size was 3.6cm (range, 1.3–6). One tumour was classified as pathological stage IA, 4 as stage IB, and 1 as IIB due to parietal pleural invasion. No patient died during the perioperative period and only one had a haemothorax which resolved with chest tube drainage. Mean hospital stay was 8.5 days (range, 7–11). The immunosuppression regimen was maintained continuously. In subsequent follow-up, 1 patient died from BC metastasis, 1 from sepsis, 1 from chronic renal failure, and 3 remained alive. The probability of survival at 5 years was 40%, and median survival was established at 5 years. ConclusionsThe incidence of BC in patients undergoing solid organ transplant and the proportion of patients diagnosed in early stages does not differ from non-transplant patients diagnosed with BC, which questions the role of immunosuppression in the genesis and aggressiveness of BC in transplant patients. Surgery may offer acceptable results in early stages, with acceptable rates of perioperative morbidity and mortality.

P-365 Imaging findings of paraneoplastic syndromes that preceded the diagnosis of bronchogenic carcinoma

P-365 Imaging findings of paraneoplastic syndromes that preceded the diagnosis of bronchogenic carcinoma

Clinical and radiological manifestations of paraneoplastic syndrome of bronchogenic carcinoma

The objective of this study was to present some clinical and radiological manifestations of PNS in relation to bronchogenic carcinoma (BC) and to evaluate the usefulness of imaging findings in the diagnosis of asymptomatic BC. In the study group of 204 patients (146 male and 58 female) with proven bronchogenic carcinoma, PNS was present in 18 (8.62%) patients. The patients with PNS were divided into two groups. The first one consisted of 13 (72.2%) patients with symptoms related to primary tumours while the second one consisted of 5 (27.7%) patients with symptoms, at initial appearance, indicative of disorders of other organs and systems. The predominant disorder was Lambert-Eaton Syndrome, associated with small-cell carcinoma. Endocrine manifestations included: inappropriate antidiuretic hormone production syndrome (small-cell carcinoma), a gonadotropin effect with gynaecomastia and testicular atrophy (planocellular carcinoma, small-cell carcinoma), a case of Cushing Syndrome (small-cell carcinoma), and hypercalcaemia, due to the production of the parathyroid hormone-related peptide, which was associated with planocellular carcinoma. A rare case of bilateral exophthalmos was found as PNS at adenocarcinoma. Digital clubbing and hypertrophic osteoarthropathy (HO) were associated with planocellular and adenocarcinoma, while clubbing was much more common than HO, especially among women. The differences between the two groups were related to the time of PNS appearance. In the first group, PNS occurred late on in the illness, while in the second group, PNS preceded the diagnosis of BC. Alternatively, the disappearance of a clinical or a radiological manifestation of PNS after surgery or chemotherapy may be an indicator of an improvement in health or PNS may be the first sign of illness recurrence. Radiological manifestations of PNS in asymptomatic patients may serve as a useful screen for identifying primary BC. In symptomatic patients, it may be an indicator of a higher likelihood of metastatic disease.

Consistency of reporting basic characteristics of lung nodules and masses on computed tomography 1

Rationale and Objectives. To assess the consistency of chest computed tomography (CT) reports in describing basic characteristics of lung nodules and masses. Materials and Methods. We retrospectively identified 107 consecutive patients with preoperative chest CT scans before resection of a lung nodule or mass over a 4-year period within a single institution. There were 54 men and 53 women with a mean age of 64 years (range, 37–86) years. The CT scans were reported by a cohort of 20 board-certified radiologists, three of whom reviewed more than 10 CT scans (n = 60 exams). The CT reports were reviewed for lesion characteristics including size, location, and description of margins, presence or absence of calcification, fat and cavitation, and the diagnosis or differential diagnosis. Pathology reports were reviewed for the same characteristics and the final diagnosis. Both CT and pathologic reports of emphysema were noted in lobectomy specimens. The differences between the interpreting radiologists were also sought. Results. A diagnosis or differential diagnosis was provided in 90% (96/107) of CT reports. The diagnosis of bronchogenic carcinoma was made in 78% (59/76) of those with bronchogenic carcinoma, compared with 65% (20/31) of those with other diagnoses ( P = NS). Radiologists described the margins of the nodule or mass in 64% (68/107) of cases, similar in frequency to 66% of pathologists (71/107). Radiologic description of an irregular/spiculated margins predicted bronchogenic carcinoma in 86% of cases (42/49), while a smooth/lobulated margins predicted a diagnosis other than bronchogenic carcinoma in 58% (11/19; P <.05). The presence or absence of calcification was noted in 7% (5/76) of cases of bronchogenic carcinoma and 32% (10/31) of those with other diagnoses ( P <.05, chi square). Both radiologists and pathologists consistently reported the size of the lesions with a correlation coefficient between radiology and pathology reports of 0.88. CT reporting of the characteristics of the lesion did not differ among lesions of different sizes. There was no significant difference between major reporters (more than 10 cases) in this study. Emphysema in the surrounding lung was reported in 25% (20/81) of radiology and 38% (31/81) of pathology reports ( P = NS). Conclusion. This series demonstrates a lack of consistent reporting of the margins of resected lung nodules both on CT and on pathologic specimens. The presence or absence of calcification was inconsistently reported, although more frequently noted in diagnoses other than bronchogenic carcinoma. As large-scale CT screening for lung cancer becomes more common, radiologists should prioritize developing and adopting standardized reporting criteria for the CT evaluation of lung nodules.

Cáncer de pulmón en el Área Sanitaria de A Coruña: incidencia, abordaje clínico y supervivencia

To determine the incidence, clinical approach, diagnostic delay and survival for bronchogenic carcinoma (BC) in the public health area of A Coruña (Spain). This was a retrospective study of patients with a diagnosis of BC made in 1995 and 1996 in a health care area with 509,000 inhabitants. For analysis we gathered demographic, clinical and cyto-histologic data and analyzed diagnostic delay, extension of disease and time of death. Crude, age-specific and age-standardized incidences were calculated. BC was diagnosed in 378 patients (95% men and 5% women). The crude incidence was 37 per 100,000 inhabitants (73.7 per 100,000 men and 3 per 100,000 women) and the age-standardized incidence was 21.7 per 100,000. Diagnosis was by cyto-histology in 87% of the cases, and the most frequent biopsy finding was epidermoid carcinoma. Diagnosis was by clinical or radiologic findings for 13.7%, and patients in that group were older and had greater comorbidity. No symptoms were present in 13% and in those patients diagnosis was earlier, with non-small BC predominating and 60% treated surgically. The diagnostic delay (time from the first symptom to histologic confirmation) was 2.5 months (median, 2.1), and length of delay did not affect survival. Surgery was performed in 23% of the patients with non-small BC. The median survival was 7.1 months (5.2 months for patients who were not treated surgically, and 37.6 for those who were). The incidence of BC in men in our study is consistent with that reported for other Spanish regions, although the incidence we observed for women is much lower. Diagnostic delay did not affect survival. The percentage of patients with surgical-stage disease is very low and survival is very short. These findings support the need for early diagnosis.

Efficacy and pattern of use of sputum cytology as a diagnostic test.

Sputum cytology is regarded by many clinicians as a noninvasive, cheap and simple test for the diagnosis of bronchogenic carcinoma. Since the introduction of fibre-optic bronchoscopy and more easily obtained bronchial biopsies reliance on sputum cytology has diminished. However, in Edinburgh it was perceived that sputum samples were still being sent as well as, rather than instead of, bronchoscopic specimens. This retrospective study was undertaken to determine whether or not cytological examination of sputum is an efficient and sensitive test in the investigation of patients with suspected bronchogenic carcinoma. It demonstrated that the Lothian University Hospitals NHS Trust Pathology Directorate receives many sputa from departments not specializing in respiratory disease when there is no indication for the test. In addition, we have shown that the absolute sensitivity of the test is only 5% and that when there is a strong clinical suspicion of bronchogenic carcinoma the results of sputum cytology do not play a significant role in the management of the patient. We recommend that sputum cytology is restricted to those patients under the care of Respiratory Units in whom bronchoscopy is inappropriate or unsuccessful.

Flexible fibreoptic bronchoscopy in Basra, Iraq: a 20-month experience

This prospective study represents our experiences in using fibreoptic bronchoscopy (FOB) in the evaluation of different thoracic lesions. Over a 20-month period, 203 patients (151 males and 52 females) (age range: 15-100 years) underwent bronchoscopies. The patients had a wide range of symptoms and/or radiographic abnormalities. The majority had cough and shortness of breath; haemoptysis was a common symptom. In all, 148 patients had neoplasms and 55 had non-neoplastic lesions. The most common malignancy was bronchogenic carcinoma (91 confirmed, 33 suspected). Other neoplasms included pulmonary metastases and mediastinal tumours. The non-neoplastic chest lesions included pulmonary tuberculosis, pulmonary hydatid cyst, lung abscess and resolving chest infection and chronic bronchitis. FOB was most useful in the diagnosis of bronchogenic carcinoma (positive diagnostic yield of 73%). It was least useful in diagnosing mediastinal tumours.

The Role of CT in the Diagnosis of Bronchogenic Carcinoma not Detected by Plain Radiograph

Purpose: To evaluate the role of CT and CT features in the diagnosis of bronchogenic carcinomas not detected by plain radiography. Materials and Methods: Eighteen patients [19 primary cancer lesions, M:F=16:2, aged 43 -75 (mean, 56.3)years] with lung cancer initially not detected by plain radiography were involved in this study. CT scanning was performed in all cases, and fibrobronchoscopy, and sputum cytology. each in 17. Lesions were divided in-to two groups: the central type, if on or proximal to the segmental bronchus, and the peripheral type, if distal to this. Plain radiographs were analysed for possible causes of occultness and for clinical characteristics including cell type, location, and size. We focused on the CT findings, comparing cases undetected by CT with those undetec6ted by bronchoscopy. Results: In the central type, the cause of occultness, as seen on plain radiographs, was small size, no secondary findings, or confusing shadow from hilar vessels. In the peripheral type, the cause was overlapping shadow due to normal structures of the chest, or combined diseases. Eight lesions were first detected by sputum cytol-ogy, 6 by bronchoscopy, and 5 by CT. Fourteen lesions were the central type (main bronchus 2, lobar bronchus 7, segmental bronchus 5), and five were peripheral. Central-type lesions were either squamous cell carcinoma (n =11), adenocarcinoma (n =1), small cell carcinoma (n =1), or large cell carcinoma (n =1). The peripheral type were either squamous cell carcinoma (n =2), adenocarcinoma (n =2), or large cell carcinoma (n =1). Size ranged from 0.2 to 4(mean, 2; central 1.7, peripheral 2.8) cm. Surgical resection was possible in 15 patients (16 cancers, including 13 at stage I). Only two were at a stage which rendered them unresectable. CT revealed 13 cancers, including all those which were peripheral. The findings were endobronchial nodule (n =4), bronchial wall thickening (n =1), perihilar mass (n =3), parenchymal mass (n =2), and subpleural mass (n =3). In six central-type cases [endobronchial mass (n =5), carcinoma in situ(n =1)], CT revealed no evidence of cancer. The mean size of these lesions was 1.1cm, and all were stage I. Bronchoscopy failed to de-tect five cases, including four peripheral cancers and one central. The mean size of these was 2.7 cm and all three adenocarcinomas were included in this group. In two of the five cases in which sputum cytology showed negative results, the existing condition was revealed by CT. Conclusion: For the detection of peripheral lung cancer, CT is better than bronchoscopy, though in cases of central lung cancer, in which CT plays a complementary role, bronchoscopy is better than complementary to bronchoscopy which is more excellent than CT in detecting central lung CT. In 68% of cases, CT revealed lung cancer which was not detected by plain radiography, and is therefore a suitable noninvasive screening method for the detection of this cancer.

Angioinvasive pulmonary carcinoma with posterior segment metastasis in four cats.

The objective of the research was to characterize the clinical, fluorescein angiographic, pathologic and microscopic features of feline pulmonary carcinoma with ocular metastasis that resulted in ischemic chorioretinopathy. Four cats with confirmed or presumed primary pulmonary neoplasia with posterior segment metastasis were studied. The medical records from four cats with a diagnosis of bronchogenic carcinoma and intraocular metastasis were reviewed. Physical and ophthalmic examinations and thoracic radiographs were performed in all cases, and fluorescein angiography was performed in two cases. Classification of the neoplasms was determined by fine-needle aspiration and biopsies of peripheral metastatic lesions, and/or complete necropsies. All four cases had unilateral or bilateral blindness and ophthalmoscopic lesions characterized by a wedge-shaped, tan discoloration in the tapetal fundus, variable but mild serous exudation under the retina, and profoundly attenuated retinal vasculature. Painful swelling and necrosis of the distal extremities and/or mass lesions in the appendicular musculature were also present. Clinical findings, along with microscopic findings from biopsy specimens or complete postmortem examination, documented widespread metastasis of variably differentiated, neoplastic, columnar epithelial cells presumed to be of bronchial origin. Tumor cells were predominately located within the systemic vasculature, consistent with classification of angioinvasive pulmonary carcinoma. Fluorescein angiographic and histopathologic findings in the affected globes suggested that the posterior segment lesions resulted from invasion and growth of neoplastic cells within the chorioretinal vasculature, resulting in secondary ischemic necrosis of the retina and choroid. Ischemic chorioretinopathy and necrosis of the distal extremities, associated with primary bronchogenic carcinoma, appear to be a unique neoplastic syndrome in the domestic cat.

Demoras en el diagnóstico y en el tratamiento quirúrgico del carcinoma broncogénico

The aim of this study was to determine the delay between clinical suspicion and diagnosis of bronchogenic carcinoma, and between diagnosis and performance of therapeutic thoracotomy. The study population included 598 patients undergoing surgery between October 1995 and September 1996 registered in the Bronchogenic Carcinoma Cooperation Group of SEPAR (BCCG-S), and 49 patients from our hospital undergoing surgery during the same period. The mean delay between diagnosis and thoracotomy was 45.15 days (SD 34.7 days) for BCCG-S patients and 53.5 days (SD 22 days) for our hospital patients. In the second group, mean time elapsing between diagnosis suspicion and performance of bronchoscopy was known to be 9.5 days (SD 14.7 days), with the lowest periods recorded for inpatients (3.1 +/- 1.7 days) and for patients who did not require chest x ray guided bronchoscopy (5 +/- 5.8 days). These data are similar to those published for hospitals in other countries. They must be considered long delays and should be shortened.

Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma

To elevate the diagnostic value of the serum cytokeratin 19 fragment (CYFRA 21-1) and compare it with carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in bronchogenic carcinoma, the sera of 161 patients (58 with benign pulmonary disease and 103 with bronchogenic carcinoma) was investigated using immunoradiometric assay. Sensitivities for CYFRA 21-1, CEA and TPA (using 3·5 ng ml −1, 5·0 ng ml −1, 110 U 1 −1, respectively, cut-off values corresponding to a 95% specificity for benign pulmonary disease) in bronchogenic carcinoma were 64, 47 and 61%, respectively. Positive CYFRA 21-1 levels were identified in 75% of patients with squamous cell carcinoma ( n=36), in 67% with adenocarcinoma ( n=45), in 17% with large cell carcinoma ( n=6), and in 50% with small cell lung cancer (SCLC) ( n=16). However, CYFRA 21-1 levels were not significantly different between squamous cell carcinoma and the other histological types. The sensitivity of the combined measurement of CYFRA 21-1 with any other tumour marker was significantly higher than that of CYFRA 21-1 measurement alone. Elevated CYFRA 21-1 levels were observed in 44% of Stages I and II ( n=18) and 72% of Stages III and IV ( n=69) patients with non-small cell lung cancer ( P<0·05). A significant inter-marker correlation was observed between CYFRA 21-1 and TPA ( n=103, r=0·448, P<0·0001). Twenty-one patients were monitored by CYFRA 21-1, and significantly different changes in progressive patients ( P=0·0058) and regressive patients ( P=0·016) were obtained. These results indicate that CYFRA 21-1 may be not only a sensitive tumour marker in the diagnosis of bronchogenic carcinoma, but also a useful marker for the monitoring of bronchogenic carcinoma.

Usefulness of LIFE in diagnosis of bronchogenic carcinoma

BACKGROUND: Although the overall prognosis of patients with lung cancer is poor, highly effective treatment exists for the small subset of patients with early lung cancer(carcinoma in situ/micro- invasive cancer). But very few patients have benefit from them because these lesions are difficult to detect and localize with conventional white-light bronchoscopy. To overcome this problem, a Lung Imaging Fluorescence Endoscopic device(LIFE) was developed to detect and clearly delineate the exact location and extent of premalignant and early lung cancer lesions using differences in tissue autofluorescence. PURPOSE: The purpose of this study was to determine the difference of sensitivity and specificity in detecting dysplasia and carcinoma between fluorescence imaging and conventional white light bronchoscopy. MATERIAL AND METHODS: 35 patients (16 with abnormal chest X-ray, 2 with positive sputum study, 2 with undiagnosed pleural effusion, 15 with respiratory symptom) hale been examined by LIFE imaging system. After a white light bronchoscopy, the patients were submitted to fluorescence bronchoscopy and the findings of both examinations have been classified in 3 categories(class I, II, III). From of all class II and III sites, 79 biopsy specimens have been collected for histologic examination: a comparison between histologic results and white light or fluorescence bronchoscopy has been performed for assessing sensitivity and specificity of the two methods. RESULTS: 1) Total 79 sites in 35 patients were examined. Histology demonstrated 8 normal mucosa, 21 hyperplasia, 23 dysplasia, and 27 microinvasive and invasive carcinoma. 2) The sensitivity of white light or fluorescence bronchoscopy in detecting dysplasia was 60.9% and 82.6%, respectively. 3) The results of. this study showed 70.3 % sensitivity for microinvasive or invasive carcinoma with LIFE system, versus 100% sensitivity for white light in 27 cases of carcinoma. The false negative study of LIFE system was 8 cases(3 adenocarcinoma and 5 small cell carcinoma), which were infiltrated in submucosal area and had normal epithelium. CONCLUSION: To improve the ability to diagnose and stage more accurately, fluorescence imaging may become an important adjunct to conventional bronchoscopic examination because of its high detection rate of premalignant and malignant epithelial lesion. But, it has limitation to detect in submucosal infiltrating carcinoma.

Bronchoscopic Ultrasonography and Brachytherapy in Roentgenologically Occult Bronchogenic Carcinoma

Bronchoscopic ultrasonography is a recently introduced technique in the diagnosis of bronchogenic carcinoma. Bronchoscopic brachytherapy is well established as a therapeutic modality in palliative therapy of advanced malignancies of the tracheobronchial tree. In an effort to combine these two modalities, we performed bronchoscopic ultrasonography in 12 patients, in all of whom bronchogenic carcinoma was histologically confirmed, although the cancers were roentgenologically occult. All 12 patients received bronchoscopic brachytherapy, and follow-up evaluations showed complete response in 11. Even though 2 patients died of other causes, the remaining 10 patients are alive at present (for an average of 6.3 months after therapy), without evidence of recurrence or distant metastases. Our experience suggests that bronchoscopic ultrasonography appears promising in the diagnosis of roentgenologically occult and bronchogenic carcinomas. The results of our study also show that in such cases bronchoscopic brachytherapy yields a high rate of therapeutic response.

Diagnosis of bronchogenic carcinoma by cytokeratin typing: Correlation with survival

Diagnosis of bronchogenic carcinoma by cytokeratin typing: Correlation with survival

Use of fiberoptic bronchoscopy in the diagnosis of bronchogenic carcinoma. A study in patients with idiopathic pleural effusions.

We reviewed our experience with 115 patients with pleural effusion in whom bronchogenic carcinoma was suspected who underwent fiberoptic bronchoscopy (FOB) to identify those for whom the procedure was useful. In 6 of 12 patients with hemoptysis, 8 of 12 with a mass or infiltrate, and 8 of 18 with atelectasis with negative fluid cytology and 3 of 7 with cytology positive, FOB was useful in diagnosis. Sixty-six patients had an isolated cytology-negative effusion. Seven of 18 with massive effusion had FOB detecting cancer. Fiberoptic bronchoscopy usually was nondiagnostic in lesser-sized effusions (47 of 48). Using outcome for those with nondiagnostic FOB, we established operating characteristics for the procedure. We conclude that FOB is useful in diagnosing bronchogenic carcinoma in such patients when there is hemoptysis, accompanying lung mass or infiltrate, atelectasis, the effusion is massive, or in cytology-positive effusions without obvious primary tumor. Due to the low prevalence of bronchogenic carcinoma in patients with effusions of lesser size, we suggest that in this group FOB not be routinely performed.

Estudio prospectivo multivariante sobre factores pronósticos en el carcinoma de pulmón no microcelular (CPNM): resultados a 5 años

We present the results of a 5-year prospective study of 153 patients with a diagnosis of bronchogenic carcinoma (BC) who underwent curative surgery. Clinical and anatomical variables were analyzed by multiple regression analysis for prediction of death. Among the anatomical variables, the most significant were the following: stages of anatomical spread (p < or = 0.00000), ganglionic state (p < or = 0.00000), type for surgery (curative or non-curative) (p < or = 0.00000) and state of tumor (p = 0.00012). Significant clinical variables were clinical stage by Feinstein's classification (p = 0.00037), functional capacity (ECOG scale) (p = 0.01196) and tumor size measured conventionally (p = 0.01196). These variables were entered into a multivariate model for prognostic prediction in order to determine the patient's relative risk over time. The best combination of anatomical variables was obtained by associating the stages of spread and ganglionic state (chi 2 = 34.24; p = < 0.00000); the best combination of clinical variables was clinical stage and tumor size (chi 2 = 17.37; p = 0.00023). Thus, although the anatomical variables are more important than clinical ones, the latter have independent prognostic value, are easy to obtain and are available before surgery. They therefore represent an alternative to prognosis based on anatomical spread.

Application of squamous cell carcinoma associated antigen monoclonal radioimmunoassay in the diagnosis of bronchogenic carcinoma : Lau-Wong MM, Kwan SYL, Yew W, Yeung DWC, Sham JST, Choy DTK. Department of Nuclear Medicine, Queen Mary Hospital, Pokfulam. Lung Cancer 1991;7:151–155

Application of squamous cell carcinoma associated antigen monoclonal radioimmunoassay in the diagnosis of bronchogenic carcinoma : Lau-Wong MM, Kwan SYL, Yew W, Yeung DWC, Sham JST, Choy DTK. Department of Nuclear Medicine, Queen Mary Hospital, Pokfulam. Lung Cancer 1991;7:151–155

Blastomycosis of the lung: CT features.

The authors reviewed the computed tomographic (CT) scans in 16 patients with pulmonary blastomycosis to describe the abnormalities seen at CT. The CT features were as follows: mass lesions (n = 14), consolidation (n = 9), air bronchograms (n = 14), intermediate-sized nodules (n = 12), satellite lesions (n = 11), pleural thickening (n = 4), small effusions (n = 2), and cavitation (n = 2). One patient had noncalcified hilar lymphadenopathy. Eight patients had acute disease, six had chronic disease, and two had acute exacerbation of a chronic illness. Fifteen patients had cough, fever, and/or dyspnea. Two patients underwent surgical resection for the presumptive diagnosis of bronchogenic carcinoma. In general, there was no correlation between the radiologic abnormalities and the clinical presentation. Consolidation occurred more frequently in acute disease. CT may be useful to help define the radiologic findings and distribution of disease. Familiarity with the characteristic CT findings of pulmonary blastomycosis may encourage an expeditious diagnostic approach to identify the disease and, possibly, prevent unnecessary surgical resection.

Application of squamous cell carcinoma associated antigen monoclonal radioimmunoassay in the diagnosis of bronchogenic carcinoma

Blood samples from 112 patients suffering from bronchogenic carcinoma prior to any form of therapy and 28 control patients were studied using the SCC RIA BEAD (Dainabot Co., Japan). The mean value of patients with squamous cell carcinoma (SCC) was 8.606 ng/ml. Triplicate tests on all samples were analyzed by the SPSS MANOVA procedure and showed an overall F-test significant at 0.0% ( P<0.05). The sensitivity of the test was 84.6%, specificity 87.7% and accuracy 87.1%. This report showed that the SCC associated antigen monoclonal radioimmunoassay can aid in the diagnosis of squamous cell carcinoma of lung. It is non-invasive, rapid in providing the result, and repeatable in the time course of disease and treatment. Further studies will be required to determine its usefulness in estimating tumor bulk, predicting the effect of treatment or recurrence, mass screening and refining histological diagnosis.

Cardiac tamponade as the initial presentation of malignancy

We describe a series of five patients who had cardiac tamponade at the time of initial presentation as a result of extracardiac malignancy. Three cases had adenocarcinoma and two had squamous cell carcinoma. The diagnosis of bronchogenic carcinoma was established after appropriate investigations in three cases. One patient possibly had a primary malignancy of the gastro-intestinal tract. The relevant literature is reviewed.